Development and characterization of biofilm | |
Introduction and Overview of Biofilm | |
Rationale for biofilm eradication from modern medical devices | |
Pathogenesis of device-related nosocomial infections | |
Biofilm resistance/tolerance to conventional antimicrobial agents | |
Analytical techniques useful to study biofilm | |
Conventional plate counting | |
Modern methods | |
Biofilm-related infections in various human organs (Nondevice-related chronic infections) | |
Biofilm-related infections in ophthalmology | |
Biofilm-related infections in oral cavity | |
Implications of biofilm formation in chronic wound and in cystic fibrosis | |
Drug delivery carriers to eradicate biofilm formation on medical devices | |
Strategies for prevention of device-related nosocomial infections | |
Novel drug delivery carriers | |
Lipid-and polymer-based drug delivery carriers | |
Liposomes as drug delivery carriers to biofilms | |
Liposomes to reduce microbial adhesion/colonisation onto medical devices | |
Liposomes as drug delivery carriers to biofilm interfaces | |
Liposomes as drug delivery carriers in intracellular infection | |
Stealth® liposomes | |
Polymer-based antimicrobial delivery carriers | |
Implantable matrices, beads, strut, microparticles, fibrous scaffolds, thermoreversible gels, etc | |
Surface modified polymeric catheter materials | |
Conclusion | |
Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.